Literature DB >> 21553316

Dynamic telecytologic evaluation of imprint cytology samples from CT-guided lung biopsies: a feasibility study.

Helmut Prosch1, Elisabeth Hoffmann, Klaus Bernhardt, Johann Schalleschak, Ewald Schober, Marcel Rowhani, Michael Weber, Gerhard Mostbeck.   

Abstract

OBJECTIVE: This study assessed the feasibility of telecytological evaluation of samples from CT-guided lung biopsies using a dynamic telecytological system in which the microscope was operated by personnel from the radiology department at the site of the biopsy and a cytologist off-site diagnosed the biopsy sample.
MATERIALS AND METHODS: 45 imprint samples from CT-guided biopsies of lung lesions were reviewed by two cytologists using a telecytological microscope (Olympus BX51, Tokyo, Japan). The telecytological microscope was operated by one radiologist and one radiology technician. The cytological samples were classified by a cytologist into four categories: benign, malignant, atypical cells of undetermined significance, and non-diagnostic. The results were compared with those of a previous consensus reading of two independent cytologists (gold standard).
RESULTS: When the radiologist was operating the microscope, the diagnostic accuracy was 100% as both cytologists came to the correct diagnosis in all samples. When the technician operated the microscope, two diagnoses of cyotologist 1 differed from the gold standard. Thus, the accuracy for the technician was 95.56%.
CONCLUSION: Telecytological evaluation of imprint samples from CT-guided lung biopsies is feasible because it can be performed with high diagnostic accuracy if personnel from the radiology department operate the microscope.

Entities:  

Mesh:

Year:  2011        PMID: 21553316     DOI: 10.1007/s00330-011-2137-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  16 in total

1.  Telecytology: intraobserver and interobserver reproducibility in the diagnosis of cervical-vaginal smears.

Authors:  P M Alli; C W Ollayos; L D Thompson; I Kapadia; D R Butler; B H Williams; D L Rosenthal; T J O'leary
Journal:  Hum Pathol       Date:  2001-12       Impact factor: 3.466

2.  Telemedicine in diagnostic pleural cytology: a feasibility study between universities in Iran and the USA.

Authors:  Hossein Ayatollahi; Alireza Khoei; Nema Mohammadian; Mohammad Hadi Sadeghian; Jafar Bordbar Azari; Mohammad Reza Ghaemi; Mahdi Khabbaz Khoob
Journal:  J Telemed Telecare       Date:  2007       Impact factor: 6.184

3.  CT-guided needle biopsy: value of on-site cytopathologic evaluation of core specimen touch preparations.

Authors:  Mei-Hua Tsou; Shu-Fen Tsai; Kwan-Yee Chan; Cheng-Fang Horng; Ming-Yuan Lee; Ai-Ying Chuang; Ming-Chih Chern
Journal:  J Vasc Interv Radiol       Date:  2008-11-22       Impact factor: 3.464

4.  Initial assessment of fine-needle aspiration specimens by telepathology: validation for use in pathology resident-faculty consultations.

Authors:  Sarah E Kerr; Andrew M Bellizzi; Edward B Stelow; Henry F Frierson; Maria Luisa C Policarpio-Nicolas
Journal:  Am J Clin Pathol       Date:  2008-09       Impact factor: 2.493

5.  Telecytology: a tool for quality assessment and improvement in the evaluation of thyroid fine-needle aspiration specimens.

Authors:  Stavros Archondakis; John Georgoulakis; Magdalini Stamataki; Dionisis Anninos; Lazaros Skagias; Ioannis Panayiotides; George Peros; Petros Karakitsos
Journal:  Telemed J E Health       Date:  2009-09       Impact factor: 3.536

6.  Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions.

Authors:  Jin Hur; Hye-Jeong Lee; Ji Eun Nam; Young Jin Kim; Tae Hoon Kim; Kyu Ok Choe; Byoung Wook Choi
Journal:  AJR Am J Roentgenol       Date:  2009-03       Impact factor: 3.959

7.  Factors affecting diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy: retrospective analysis of 631 procedures.

Authors:  Kee-Min Yeow; Pei-Kwei Tsay; Yun-Chung Cheung; Kar-Wai Lui; Kuang-Tse Pan; Andy Shau-Bin Chou
Journal:  J Vasc Interv Radiol       Date:  2003-05       Impact factor: 3.464

8.  Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature.

Authors:  J H Austin; M B Cohen
Journal:  AJR Am J Roentgenol       Date:  1993-01       Impact factor: 3.959

9.  Usefulness of core roll preparations in immediate assessment of neoplastic lung lesions: comparison to conventional CT scan-guided lung fine-needle aspiration cytology.

Authors:  Vishal S Chandan; Kelly Zimmerman; Paul Baker; Ernest Scalzetti; Kamal K Khurana
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  Dynamic telecytopathology of on site rapid cytology diagnoses for pancreatic carcinoma.

Authors:  Burton Kim; David C Chhieng; David R Crowe; Darshana Jhala; Nirag Jhala; Thomas Winokur; Mohamad A Eloubeidi; Isam E Eltoum
Journal:  Cytojournal       Date:  2006-12-11       Impact factor: 2.091

View more
  3 in total

Review 1.  The Empirical Foundations of Telepathology: Evidence of Feasibility and Intermediate Effects.

Authors:  Rashid L Bashshur; Elizabeth A Krupinski; Ronald S Weinstein; Matthew R Dunn; Noura Bashshur
Journal:  Telemed J E Health       Date:  2017-02-07       Impact factor: 3.536

2.  Effectiveness of combined use of imprint cytological and histological examination in CT-guided tissue-core biopsy.

Authors:  Takuji Yamagami; Rika Yoshimatsu; Kenji Kajiwara; Masaki Ishikawa; Tomohiro Matsumoto; Hideaki Kakizawa; Naoyuki Toyoda; Terumitsu Hasebe; Kazuo Awai
Journal:  Eur Radiol       Date:  2014-02-14       Impact factor: 5.315

3.  Diagnostic efficiency and safety of rapid on-site evaluation combined with CT-guided transthoracic core needle biopsy in suspected lung cancer patients.

Authors:  Ruzetuoheti Yiminniyaze; Xiujuan Zhang; Yuanyuan Zhang; Kun Chen; Chengwei Li; Ning Zhu; Daibing Zhou; Jing Li; Yuhai Zhang; Shengqing Li
Journal:  Cytopathology       Date:  2022-05-10       Impact factor: 1.286

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.